Capitolis Advisors LLC Merck & Co., Inc. Transaction History

Capitolis Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $710,666 - $805,575	-8,512 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $15.2 Million - $17 Million	-206,774 Reduced 96.05%	8,512 $698,000
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $2.31 Million - $2.9 Million	32,007 Added 17.46%	215,286 $16.5 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $66,447 - $73,075	-927 Reduced 0.5%	183,279 $14.1 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $7.01 Million - $7.75 Million	-99,716 Reduced 35.12%	184,206 $14.3 Million

Q4 2020 May 07, 2021	BUY	$71.77 - $79.65 $20.4 Million - $22.6 Million	283,922 New	283,922 $23.2 Million

3,768

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $319B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.